Chami Karim, Khaleq Khalid K, El Goubi Manal, Moussaoui Mohmmed, El Aidaoui Karim
Anesthesia and Critical Care, Hôpital Universitaire International Cheikh Khalifa Ibn Zaid/Faculty of Pharmacy, Mohammed VI University of Health Sciences, Casablanca, MAR.
Anesthesia and Critical Care, Centre Hospitalo-Universitaire Ibn Rochd/Université Hassan II de Casablanca, Casablanca, MAR.
Cureus. 2025 Aug 8;17(8):e89597. doi: 10.7759/cureus.89597. eCollection 2025 Aug.
Acyclovir is a widely used antiviral medication known for its potential nephrotoxic effects. These adverse effects may include acute kidney injury (AKI), acute tubulointerstitial nephritis, crystal-induced nephropathy, and, in rare cases, tubular dysfunction. While acyclovir is generally considered safe, nephrotoxicity can occur, particularly when administered at high doses or in dehydrated patients. We present the case of a 20-year-old woman who was previously in good health but developed acute kidney failure 48 hours after initiating intravenous acyclovir at a standard meningeal dose of 15 mg/kg every eight hours for suspected herpetic meningoencephalitis. Upon suspicion of drug-induced nephrotoxicity, acyclovir was discontinued, leading to a rapid improvement in renal function within 24 hours. This case highlights the importance of close monitoring in patients receiving acyclovir, particularly those at an increased risk of nephrotoxicity. To ensure early detection and intervention, it is crucial to perform regular renal function assessments, especially within the first 48 hours of treatment.
阿昔洛韦是一种广泛使用的抗病毒药物,以其潜在的肾毒性作用而闻名。这些不良反应可能包括急性肾损伤(AKI)、急性肾小管间质性肾炎、晶体诱导的肾病,以及在罕见情况下的肾小管功能障碍。虽然阿昔洛韦通常被认为是安全的,但肾毒性仍可能发生,尤其是在高剂量给药或脱水患者中。我们报告一例20岁女性病例,该患者此前身体健康,但在以每8小时15mg/kg的标准脑膜剂量静脉注射阿昔洛韦治疗疑似疱疹性脑膜脑炎48小时后出现急性肾衰竭。在怀疑药物性肾毒性后,停用了阿昔洛韦,肾功能在24小时内迅速改善。该病例强调了对接受阿昔洛韦治疗的患者进行密切监测的重要性,尤其是那些肾毒性风险增加的患者。为确保早期发现和干预,定期进行肾功能评估至关重要,尤其是在治疗的前48小时内。